Further experiments with the skin of IL-6−/− or IL-6+/+ C57BL/6 mice treated with DMBA plus okadaic acid, or DMBA plus TPA, revealed that the IL-6−/− and IL-6+/+ groups did not show any significant difference in their tumor-promoting activities. The gene discussed is IL6; the disease is neoplasm.